abrdn Healthcare Investors Shares of Beneficial Interest (HQH)

FairStock Score: 43/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Looking at abrdn Healthcare Investors, I see a closed-end equity fund, not an operating business. Its economic engine is the manager's ability to pick healthcare stocks, mainly small-cap growth names in biotechnology, devices, and pharmaceuticals. That can be a fertile hunting ground, but it is also volatile, and the fund itself has no conventional moat beyond abrdn's research process and the closed-end structure. On the numbers supplied, the valuation case is striking: at the 2026-10-13 close of $19.13, FairStock calculates a P/E of 4.28, a P/B of 0.96, and a Graham Number of $44.71, giving a 57.21% margin of safety. The dividend yield is 12.91%, and beta is 0.75, so income and lower volatility are part of the appeal. But quality signals are mixed. FairStock's ROE is 24.21%, yet ROCE is -0.35% and the Piotroski F-Score is 0/9. For a fund, the Altman Z-Score of 216.73 is not a meaningful solvency test, and D/E is not available. The lack of filed annual results, only 0 years, prevents a Lynch category and leaves no revenue, profit, or growth history to judge. My Graham instinct says the price is cheap against book and the Graham Number. My Buffett instinct says I need clearer evidence that the high distribution is covered by durable investment returns, not just capital. Until then, it is a statistically cheap but unproven special situation.

In plain English: abrdn Healthcare Investors is a closed-end fund that invests in healthcare stocks, mostly smaller growth companies. Its business looks mixed: it pays a very high income and trades below some calculated value measures, but its financial quality signals are weak and there is little filed history. Based on the numbers given, the price looks cheap compared with book value and earnings, but that cheapness comes with real uncertainty.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer